A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
This study enrolls children with schizophrenia. The purpose of this study is to learn if the study medication (cariprazine) is safe and useful for adolescents ages 13-17.
Your child will be in this study for about 3 months. After your child's first visit, they will come to our office 7 times. During this time your child will undergo various procedures and examinations. Your child will be randomly assigned (like drawing straws) to one of three groups. Two groups will take different amounts of the study drug and one group will take a placebo. A placebo looks like the study drug but has no active ingredients. Neither you, your child, or the study team will know which group your child is in.
The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
-Children ages 13-17.
-Diagnosed with schizophrenia.
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the
contact information above or email firstname.lastname@example.org and someone will assist you.
Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality
assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided
in the aforementioned ways, please contact email@example.com.